POCL Enterprises Share Price

174.10-0.15 (-0.08%)

BSE

Pre Open
As On:
As On: 24 Jun, 2026, 09:07 AM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-174.10
Previous Day	-174.25

POCL Enterprises Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all POCL Enterprises Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	333.23	366.20	363.57	373.49	373.32
Total Income Growth (%)	-9.00	0.72	-2.66	0.05	2.55
Total Expenses	316.46	349.79	345.85	354.15	355.58
Total Expenses Growth (%)	-9.53	1.14	-2.34	-0.40	1.20
EBIT	16.78	16.41	17.72	19.34	17.74
EBIT Growth (%)	2.24	-7.38	-8.40	9.02	39.99
Profit after Tax (PAT)	12.80	9.09	8.26	11.33	10.52
PAT Growth (%)	40.76	10.09	-27.07	7.65	67.48
EBIT Margin (%)	5.03	4.48	4.87	5.18	4.75
Net Profit Margin (%)	3.84	2.48	2.27	3.03	2.82
Basic EPS (₹)	4.25	3.04	2.80	4.11	3.77

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	333.23	366.20	363.57	373.49	373.32
Total Income Growth (%)	-9.00	0.72	-2.66	0.05	9.42
Total Expenses	316.46	349.79	345.85	354.15	355.58
Total Expenses Growth (%)	-9.53	1.14	-2.34	-0.40	8.09
EBIT	16.78	16.41	17.72	19.34	17.74
EBIT Growth (%)	2.24	-7.38	-8.40	9.02	45.20
Profit after Tax (PAT)	9.70	8.51	9.76	11.64	10.52
PAT Growth (%)	13.99	-12.74	-16.20	10.65	87.40
EBIT Margin (%)	5.03	4.48	4.87	5.18	4.75
Net Profit Margin (%)	2.91	2.32	2.68	3.12	2.82
Basic EPS (₹)	3.22	2.84	3.30	4.11	3.77

	FY 2026
Total Revenue	1,435.47
Total Revenue Growth (%)	-
Total Expenses	1,381.60
Total Expenses Growth (%)	-
Profit after Tax (PAT)	41.48
PAT Growth (%)	-
Operating Profit Margin (%)	4.92
Net Profit Margin (%)	2.89
Basic EPS (₹)	13.76

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,435.47	1,451.33	1,120.84	874.89	498.21
Total Revenue Growth (%)	-1.09	29.49	28.11	75.61	55.66
Total Expenses	1,381.60	1,409.53	1,096.96	857.73	495.01
Total Expenses Growth (%)	-1.98	28.49	27.89	73.27	55.51
Profit after Tax (PAT)	39.61	31.18	17.74	12.89	3.37
PAT Growth (%)	27.04	75.76	37.61	282.38	132.65
Operating Profit Margin (%)	4.92	4.17	3.34	3.13	1.98
Net Profit Margin (%)	2.76	2.15	1.58	1.47	0.67
Basic EPS (₹)	13.14	11.18	31.81	23.12	6.05

All figures in Rs Cr, unless mentioned otherwise

Insights

Topline Contraction
Sales de-grew by 1.09%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent 1.16% of its operating revenues towards interest expenses and 1.98% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026
Total Assets	364.63
Total Assets Growth (%)	-
Total Liabilities	170.08
Total Liabilities Growth (%)	-
Total Equity	194.55
Total Equity Growth (%)	-
Current Ratio (x)	1.87
Total Debt to Equity (x)	0.68
Contingent Liabilities	0.00

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	362.76	225.61	198.77	162.72	150.30
Total Assets Growth (%)	60.79	13.50	22.15	8.26	14.93
Total Liabilities	170.08	127.71	130.62	111.18	111.63
Total Liabilities Growth (%)	33.18	-2.23	17.49	-0.40	16.85
Total Equity	192.68	97.90	68.14	51.54	38.67
Total Equity Growth (%)	96.81	43.67	32.21	33.28	9.70
Current Ratio (x)	1.87	1.53	1.35	1.35	1.22
Total Debt to Equity (x)	0.68	1.07	1.54	1.75	2.21
Contingent Liabilities	0.00	4.34	4.00	0.97	0.13

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026
Net Cash flow from Operating Activities	26.23
Net Cash used in Investing Activities	-75.95
Net Cash flow from Financing Activities	65.69
Net Cash Flow	15.96
Closing Cash & Cash Equivalent	15.98
Closing Cash & Cash Equivalent Growth (%)	-
Total Debt/ CFO (x)	5.03

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	26.23	40.43	2.59	6.41	7.31
Net Cash used in Investing Activities	-75.95	-19.61	-2.81	-1.09	-0.60
Net Cash flow from Financing Activities	65.69	-20.82	0.23	-5.77	-6.27
Net Cash Flow	15.96	0.00	0.01	-0.45	0.44
Closing Cash & Cash Equivalent	15.98	0.02	0.02	0.01	0.46
Closing Cash & Cash Equivalent Growth (%)	0.01	-13.84	163.53	-98.15	2,013.82
Total Debt/ CFO (x)	5.03	2.59	40.55	14.05	11.69

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 26.23 cr is 0.63 times compared to the reported net profit of Rs 41.48 cr. (Source: Consolidated Financials)
Increase in Cash from Investing
Company has used Rs 75.95 cr for investing activities which is an YoY increase of 287.38%. (Source: Standalone Financials)

View Details

Ratios

Annual	FY 2026
Return on Equity (%)	21.32
Return on Capital Employed (%)	33.85
Return on Assets (%)	11.37
Interest Coverage Ratio (x)	4.57
Asset Turnover Ratio (x)	-
Price to Earnings (x)	10.86
Price to Book (x)	2.31
EV/EBITDA (x)	7.43
EBITDA Margin (%)	5.31

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	20.55	31.84	26.03	25.01	8.71
Return on Capital Employed (%)	34.16	55.08	47.45	41.80	18.41
Return on Assets (%)	10.91	13.81	8.92	7.92	2.24
Interest Coverage Ratio (x)	4.57	3.41	2.88	2.85	1.75
Asset Turnover Ratio (x)	4.87	6.83	6.20	5.59	3.54
Price to Earnings (x)	11.36	19.53	8.81	5.05	10.43
Price to Book (x)	2.34	6.21	2.29	1.26	0.91
EV/EBITDA (x)	7.43	11.02	6.63	5.22	10.04
EBITDA Margin (%)	5.31	4.40	3.50	3.33	2.34

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
POCL Enterprises	13.03	2.78	21.32	33.85	11.37	17.75	4.92	2.76	13.76	1.87	0.68	5.03
Kilitch Drug	22.11	2.41	10.78	13.15	6.59	19.85	18.77	12.52	8.91	1.83	0.32	3.70
Zim Laboratories	110.15	2.17	1.97	6.13	1.08	-1.59	5.71	1.55	1.19	1.45	0.42	2.48
Praveg Comm	-55.54	1.37	-2.56	1.72	-1.61	41.40	4.25	-4.13	-3.81	1.40	0.13	0.98
Jenburkt Pharma	14.33	2.53	17.62	25.10	15.36	7.98	30.18	20.58	78.71	4.11	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

Bafna Pharma
Transchem Ltd
Albert David
SMS Lifesciences Ind
Medico Remedies

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
POCL Enterprises Stock Performance	0.14	-5.16	-5.61	-4.12	-26.99	592.55	1805.64
Kilitch Drug Stock Performance	0.55	22.67	33.58	21.11	-19.11	73.49	135.55
Zim Laboratories Stock Performance	-4.14	20.60	43.42	69.32	35.87	18.94	300.67
Praveg Comm Stock Performance	4.52	-7.72	-4.43	-9.28	-52.44	-48.00	272.91
Jenburkt Pharma Stock Performance	0.37	-4.85	6.20	9.92	-2.07	54.27	135.49
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	1,23,93,405	40.28 %	0.13
Pledge	0	0.00 %	0.00
FII	74,258	0.24 %	0.00
Others	1,82,98,420	59.48 %	-0.13

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	40.28	40.15	40.15	40.15
Pledge	0.00	0.00	0.00	0.00
FII	0.24	0.24	0.24	0.24
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	59.48	59.61	59.61	59.61

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Final
40%
May 25, 2026
Board Meeting
Audited Results & Final Dividend
May 19, 2026
Board Meeting
Quarterly Results
Feb 06, 2026

Board Meetings

Announced on	Meeting on
May 19, 2026	May 25, 2026
Audited Results & Final Dividend
Feb 06, 2026	Feb 13, 2026
Quarterly Results
Nov 06, 2025	Nov 14, 2025
Quarterly Results & Interim Dividend
Aug 04, 2025	Aug 11, 2025
Quarterly Results
Apr 30, 2025	May 05, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
Nov 14, 2025 Nov 20, 2025 20%
May 05, 2025 Sep 04, 2025 35%
May 29, 2024 Aug 30, 2024 25%
May 29, 2023 Sep 13, 2023 20%
May 25, 2026 - 40%
Bonus
No Data Available
Splits
Announced on Ex-Date
Aug 01, 2024 Oct 25, 2024
Split: Old FV10.0| New FV:2.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Aug 11, 2025 Sep 26, 2025
-
Apr 03, 2025 Apr 28, 2025
-
Aug 02, 2024 Sep 23, 2024
-
Aug 14, 2023 Sep 20, 2023
A.G.M.
Sep 02, 2022 Sep 29, 2022
-

Announced on	Ex-Date	Dividend%
Nov 14, 2025	Nov 20, 2025	20%
May 05, 2025	Sep 04, 2025	35%
May 29, 2024	Aug 30, 2024	25%
May 29, 2023	Sep 13, 2023	20%
May 25, 2026	-	40%

Announced on	Ex-Date
Aug 01, 2024	Oct 25, 2024
Split: Old FV10.0\| New FV:2.0

Announced on	Meeting on
Aug 11, 2025	Sep 26, 2025
-
Apr 03, 2025	Apr 28, 2025
-
Aug 02, 2024	Sep 23, 2024
-
Aug 14, 2023	Sep 20, 2023
A.G.M.
Sep 02, 2022	Sep 29, 2022
-

About POCL Enterprises

POCL Enterprises Ltd., incorporated in the year NA, is a Small Cap company (having a market cap of Rs 540.56 Crore) operating in Pharmaceuticals sector.

POCL Enterprises Ltd. key Products/Revenue Segments include Metals, Metallic Oxides, PVC Stabilisers, Others, Other Operating Revenue, Sale of services for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 333.23 Crore, down 9.00 % from last quarter Total Income of Rs 366.20 Crore and down 10.74 % from last year same quarter Total Income of Rs 373.32 Crore. Company has reported net profit after tax of Rs 9.70 Crore in latest quarter.

The company’s top management includes Mr.Devakar Bansal, Mr.Sunil Kumar Bansal, Mr.Amber Bansal, Mr.Harsh Bansal, Mrs.Nupur Bansal, Mr.Sagar Bansal, Mr.Harish Kumar Lohia, Dr.Padam C Bansal, Mr.Indu Bala, Mr.Jyoti Kumar Chowdhry, Dr.Ramachandran Balachandran, Mr.Shyam Sunder Tikmani, Mr.Aashish Kumar K Jain. Company has Darpan & Associates as its auditors. As on 31-03-2026, the company has a total of 3.08 Crore shares outstanding.

POCL Enterprises Share Price Today is Rs. 174.10. On previous day, the POCL Enterprises Share Price (NSE) closed at Rs. 175.45, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 40.28% of the stake in POCL Enterprises shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of POCL Enterprises stocks was 0.24% as compared to 0.24% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in POCL Enterprises shares 0.0% was held by mutual funds. The rest including public held is 0.0%. POCL Enterprises stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
POCL Enterprises Dividend: Ever since 0, POCL Enterprises dividends has been paid out around 8 times. As on 24 Jun, 2026, 09:07 AM IST, The overall dividend yield for POCL Enterprises stands at 0.68%. The last dividend paid was on November 20, 2025 (Rs. 0.4). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 13.48.

POCL Enterprises Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 333.23 Cr. of sales and 9.0% of quarterly net loss, there have been multiple ups and downs in the POCL Enterprises stock prices in the past few weeks. For example, POCL Enterprises stock price on 16th of June 2026 was around Rs. 177.9. POCL Enterprises share price now stands at an average of Rs. 174.10. Judging by last week's performance, stock is in down trend.

POCL Enterprises has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for POCL Enterprises share.

Historical Prices and Performance:
POCL Enterprises, incorporated in 0 is a Small Cap company (with a market cap of Rs. 540.56) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by POCL Enterprises stock was 21.32%, 31.84%, 26.03%, 25.01% and 8.71% respectively.
The POCL Enterprises share gave a 3 year return of 405.03% as compared to Nifty 50 which gave a return of 27.64%.
POCL Enterprises announced 20.0% final dividend on November 20, 2025.

Key Metrics:
PE Ratio of POCL Enterprises is 13.03
Prices/Sales Ratio of POCL Enterprises is 0.31
Price/Book Ratio of POCL Enterprises is 2.78

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 13.03 and 2.78 respectively.

Leadership of POCL Enterprises :
Aashish Kumar K Jain is Co. Secretary & Compl. Officer
Padam C Bansal is Non Executive Director
Devakar Bansal is Managing Director
Sunil Kumar Bansal is Managing Director
Amber Bansal is WholeTime Director & CFO
Harsh Bansal is Whole Time Director
Sagar Bansal is Whole Time Director
Nupur Bansal is Whole Time Director
Harish Kumar Lohia is Non Executive Director
Shyam Sunder Tikmani is Independent Director
Jyoti Kumar Chowdhry is Independent Director
Indu Bala is Independent Director
Ramachandran Balachandran is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

-

Address

Willingdon Crescent, 1st Floor,No. 6/2, Pycrofts Garden Road,Chennai (Madras), Tamil Nadu - 600006

Contact

info@poel.in

http://www.poel.in

PE Ratio(x)	12.91
EPS - TTM(₹)	13.48
MCap(₹ Cr.)	540.56
MCap Rank	100
PB Ratio(x)	2.78
Div Yield(%)	0.69
Face Value(₹)	2.00
52W High(₹)	290.00
52W Low(₹)	142.00
MCap/Sales	0.31
Beta(1 Month)	0.17
BV/Share(₹)	63.23

1 Day	-0.08%
1 Month	-5.99%
3 Months	5.2%
1 Year	-18.7%
3 Years	400.43%
5 Years	1553.37%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

POCL Enterprises Share Price

Key Metrics